These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33850271)

  • 1. Pattern of inflammatory immune response determines the clinical course and outcome of COVID-19: unbiased clustering analysis.
    Lee EE; Song KH; Hwang W; Ham SY; Jeong H; Kim JH; Oh HS; Kang YM; Lee EB; Kim NJ; Chin BS; Park JK
    Sci Rep; 2021 Apr; 11(1):8080. PubMed ID: 33850271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predication of oxygen requirement in COVID-19 patients using dynamic change of inflammatory markers: CRP, hypertension, age, neutrophil and lymphocyte (CHANeL).
    Lee EE; Hwang W; Song KH; Jung J; Kang CK; Kim JH; Oh HS; Kang YM; Lee EB; Chin BS; Song W; Kim NJ; Park JK
    Sci Rep; 2021 Jun; 11(1):13026. PubMed ID: 34158545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management.
    Marté JL; Toney NJ; Cordes L; Schlom J; Donahue RN; Gulley JL
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33219091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in immune responses to SARS-CoV-2 in patients with COVID-19.
    Zhao G; Xu Y; Li J; Cui X; Tan X; Zhang H; Dang L
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33350432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study.
    Zhang J; Wang Z; Wang X; Hu Z; Yang C; Lei P
    Front Immunol; 2021; 12():581469. PubMed ID: 33664741
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness.
    Rokni M; Ahmadikia K; Asghari S; Mashaei S; Hassanali F
    BMC Infect Dis; 2020 Nov; 20(1):869. PubMed ID: 33225909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome.
    Lee RJ; Wysocki O; Bhogal T; Shotton R; Tivey A; Angelakas A; Aung T; Banfill K; Baxter M; Boyce H; Brearton G; Copson E; Dickens E; Eastlake L; Gomes F; Hague C; Harrison M; Horsley L; Huddar P; Hudson Z; Khan S; Khan UT; Maynard A; McKenzie H; Palmer D; Robinson T; Rowe M; Thomas A; Tweedy J; Sheehan R; Stockdale A; Weaver J; Williams S; Wilson C; Zhou C; Dive C; Cooksley T; Palmieri C; Freitas A; Armstrong AC
    ESMO Open; 2021 Feb; 6(1):100005. PubMed ID: 33399072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19.
    Shaath H; Vishnubalaji R; Elkord E; Alajez NM
    Cells; 2020 Oct; 9(11):. PubMed ID: 33138195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.
    Pan F; Yang L; Li Y; Liang B; Li L; Ye T; Li L; Liu D; Gui S; Hu Y; Zheng C
    Int J Med Sci; 2020; 17(9):1281-1292. PubMed ID: 32547323
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic implications of neutrophil-lymphocyte ratio in COVID-19.
    Jimeno S; Ventura PS; Castellano JM; García-Adasme SI; Miranda M; Touza P; Lllana I; López-Escobar A
    Eur J Clin Invest; 2021 Jan; 51(1):e13404. PubMed ID: 32918295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia.
    Zhou Y; Guo S; He Y; Zuo Q; Liu D; Xiao M; Fan J; Li X
    Front Cell Infect Microbiol; 2020; 10():322. PubMed ID: 32612961
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical characteristics and peripheral immunocyte subsets alteration of 85 COVID-19 deaths.
    Xiong L; Zang X; Feng G; Zhao F; Wang S; Zeng W; Yu K; Zhai Y
    Aging (Albany NY); 2021 Mar; 13(5):6289-6297. PubMed ID: 33711813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex- and age-specific clinical and immunological features of coronavirus disease 2019.
    Jin S; An H; Zhou T; Li T; Xie M; Chen S; Chen C; Ying B; Xu Z; Li X; Li M
    PLoS Pathog; 2021 Mar; 17(3):e1009420. PubMed ID: 33770147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can COVID-19 Mortality be Predicted in the Emergency Room?
    Güneysu F; Guner NG; Erdem AF; Durmus E; Durgun Y; Yurumez Y
    J Coll Physicians Surg Pak; 2020 Sep; 30(9):928-932. PubMed ID: 33036676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gradient of Immune/Inflammatory Response and COVID-19 Prognosis with Therapeutic Implications.
    Zheng M
    Front Immunol; 2021; 12():739482. PubMed ID: 34777350
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.
    Urra JM; Cabrera CM; Porras L; Ródenas I
    Clin Immunol; 2020 Aug; 217():108486. PubMed ID: 32479985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory biomarkers of COVID-19 disease severity and outcome: Findings from a developing country.
    Leulseged TW; Hassen IS; Ayele BT; Tsegay YG; Abebe DS; Edo MG; Maru EH; Zewde WC; Naylor LK; Semane DF; Dresse MT; Tezera BB
    PLoS One; 2021; 16(3):e0246087. PubMed ID: 33720944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study.
    Mousavi SA; Rad S; Rostami T; Rostami M; Mousavi SA; Mirhoseini SA; Kiumarsi A
    Hematology; 2020 Dec; 25(1):383-388. PubMed ID: 33124971
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictive Nomogram for Severe COVID-19 and Identification of Mortality-Related Immune Features.
    Cai L; Zhou X; Wang M; Mei H; Ai L; Mu S; Zhao X; Chen W; Hu Y; Wang H
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):177-184.e3. PubMed ID: 33160092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in patients admitted to an urban teaching hospital with COVID-19 infection.
    Maguire D; Woods M; Richards C; Dolan R; Veitch JW; Sim WMJ; Kemmett OEH; Milton DC; Randall SLW; Bui LD; Goldmann N; Cameron A; Laird B; Talwar D; Godber I; Davidson A; McMillan DC
    J Transl Med; 2020 Sep; 18(1):354. PubMed ID: 32933530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.